Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) TrialMichael R. Gold, Gregory Granrud, Craig Barr et al.|Circulation|2020Cited by 219
Myocardial Damage in Patients with Sarcoidosis and Preserved Left Ventricular Systolic Function: An Observational StudyAmit R. Patel, John F. Beshai, Michael R. Klein et al.|European Journal of Heart Failure|2011Cited by 116
Influence of late gadolinium enhancement on left ventricular morphology and function in patients with sarcoidosisAmit R. Patel, John F. Beshai, Nadera Sweiss et al.|Journal of Cardiovascular Magnetic Resonance|2009Cited by 3
ARE ATRIAL ARRHYTHMIAS UNDER-RECOGNIZED IN PATIENTS WITH CARDIAC SARCOIDOSIS?Matthew Cain, John F. Beshai, Mark D. Metzl et al.|Journal of the American College of Cardiology|2012Cited by 1
CARDIAC SARCOIDOSIS WITH PRESERVED SYSTOLIC FUNCTION: IMPACT OF LATE GADOLINIUM ENHANCEMENT ON DIASTOLIC FUNCTION AND LEFT ATRIAL MORPHOLOGYAmit R. Patel, John F. Beshai, D. Kyle Hogarth et al.|Journal of the American College of Cardiology|2010Cited by 0